Sun Pharma Advanced Research Company Limited Cash Flow Reinvestment Rate

Latest as of December 2023: 0.00x

Sun Pharma Advanced Research Company Limited cash flow reinvestment rate. Sun Pharma Advanced Research Company Limited (SPARC) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs63.20 Million. Explore SPARC operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

Rs0.00
Capex + Investments

Operating Cash Flow

Rs63.20 Million
INR

Capital Expenditures

Rs0.00
INR

Cash Flow Reinvestment Rate of Sun Pharma Advanced Research Company Limited (2009–2014)

Cash flow reinvestment rate of Sun Pharma Advanced Research Company Limited from 2009 to 2014. Historical reinvestment intensity for Sun Pharma Advanced Research Company Limited across 4 annual periods. Explore SPARC capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Sun Pharma Advanced Research Company Limited Cash Flow Reinvestment Rate by Year (2009–2014)

Sun Pharma Advanced Research Company Limited cash flow reinvestment rate by year from 2009 to 2014. Year-by-year capital reinvestment analysis for Sun Pharma Advanced Research Company Limited. For the full cash flow conversion analysis, see how efficiently does Sun Pharma Advanced Research Company Lim generate cash.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2014 2.68x Rs987.15 Million Rs368.95 Million Rs36.74 Million ▲ +41.6%
2011 1.89x Rs47.34 Million Rs25.05 Million Rs47.34 Million ▲ +191.8%
2010 0.65x Rs81.83 Million Rs126.34 Million Rs81.83 Million ▼ -37.2%
2009 1.03x Rs262.35 Million Rs254.54 Million Rs262.35 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow